DOCSLIB.ORG

Laws and Regulations

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

E/NL. 1964/2 11 June 1964 UNITED NATIONS ENGLISH ONLY Original: GERMAN LAWS AND REGULATIONS PROMULGATED TO GIVE EFFECT TO THE PROVISIONS OF THE CONVENTION OF 13 JULY 1931 FOR LIMITING THE MANUFACTURE AND REGULATING THE DISTRIBUTION OF NARCOTIC DRUGS, AS AMENDED BY THE PROTOCOL OF 11 DECEMBER 1946 AUSTRIA Communicated by the Government of Austria NOTE BY THE SECRETARY-GENERAL -- In accordance with Article 21 of the Convention of 13 July 1931 for Limiting the Manufacture and Regulating the Distribution of Narcotic Drugs, as amended by the Protocol of 11 December 1946, the Secretary-General has the honour to communicate the following legislative text. "Bundesgesetzblatt" of the Republic of Austria, Part 34 21 June 1963 ORDER OF THE FEDERAL MINISTRY OF SOCIAL ADMINISTRATION, AMENDING THE NARCOTIC DRUGS ORDER, BUNDESGESETZBLATT No. 19/1947, (FIFTH AMENDMENT) No. 128 21 March 1963 Pursuant to the Narcotic Drugs Act 1951, Bundesgesetzblatt No. 234^, Section 1, subsection 2, the following is hereby ordered with the concurrence of the Federal Ministries of Agriculture and Forests and of Commerce and Reconstruction: The Narcotics Drugs Order, Bundesgesetzblatt No. 19/1947^, as amended by the Narcotic Drugs (4th Amendment) Order, Bundesgesetzblatt No. 234/1958,-^ is hereby amended and supple• mented as follows: 1. Section 1, subsection l,(b) and (c) shall read: "(b) Morphine, Diacetylmorphine /heroin/,^ Dihydromorphine, 6-methyldihydromorphine (methvldihvdromorphine)^ "y[ 14-hydroxydihydromorphine (hvdromorphinol). i/ Note bv the Secretariat: E/NL.1960/11. 2/ Note bv the Secretariat: E/NL.1949/36. 3/ Note bv the Secretariat: E/NL.1959/30. 4/ Note bv the Secretariat: The words in square brackets have been inserted by the Secretariat. J5/ Note bv the Secretariat: Proposed or recommended international non-proprietary names- of drugs are underlined. - 2 - Dihydrodeoxymorphine ( riflyf»"rphine). 6-»ethyl-delta-6-deoxyiaorphine (methyldeaornhine). Mo rpho 1 i ny 1 e thylinor phi ne (pholcodine). Morphine-N-'Oxide (morphine aminoxide), Pentavalent nitrogen norphine derivatives, Ethylaorphine, Benzylaorphine, No morphine. Dihydroiwrphinone (hvdr oaornhone). 5-methyldihydromorphinone (motonon). 14-hydroxydihydromorphinone (oxvmorphone). Codeine, Dihydrocodeine, Dihydrocodeinone (hvdrocodone). Acetyldihydrocodeine, Acetyldihydrocodeinone (acetyldeaetbylodihydrothebaine, thebacon), 14—hydroxydihydrocodeinone (oxycodone). Codeine-N-oxide, Norcodeine. Thebaine, (c) 1-tnethyl—4—phenylpi per idine-4—carboxylic acid esters (for example, pethidine). l-(2-(p-a«inophenyl)-etbyl)-4—phenylpiperidine—4-carboxylic acid etbyl ester /l-para-aminoT>henethvl-4-T>henYlpiperidine-4-carboxylic acid ethyl ester/ (*ni1uridineL l-(2-benzyloxyetbyl)-4-phenylpiperidine-4-carboxylic acid etbyl ester (benxethidine). l-(3-cyano-3,3-diphenylpropyl)-4-phenylpiperidine-4-carboxylic acid ethyl ester (diphenoxylate). l-(2-(2-hydroxyethoxy)-ethyl)—4-phenylpiperidine-4-carboxylic acid etbyl ester (etoxeridine). l-(3-hydroxy-3-phenylpropyl)—4-phenylpiperidine-4—carboxylic acid ethyl ester (pheaoperidine). 4-meta-hvdroxvt)henvl-l-nethvlpiperidine-4-carboxvlic acid etbyl ester (hydroxy-pethidine ) . 4—meta-hvdroxvphenvl-1-ieth.yl—4-propionylpiperidine (ketobemidone), 1—(2-morpholinoethyl)—4—phenylpiperidine—4-carboxylic acid etbyl ester 4—phenyl-l-(3-phenylaminopropyl)-piperidine-4—carboxylic acid etbyl ester (piminodino). - 3 - 4-phenylpiperidine—4—carboxylic acid ethyl ester (pethidine-intermediate-iB), l-(2-tetrahydrofurfuryloxyethyl)-4-phenylpiperidine-4-carboxylic acid ethyl ester (furethidine). 4—cyano-l-methyl—4-phenylpiperidine (pethidine-intermediate-A), 3-allyl-l-methyl-4-phenyl-4-propionoxypiperidine (allvlprodine), alpha-1,3-dimethyl-4-phenyl-4-propionoxypiperidine (alohanrodine), beta-1,3-dimetbyl-4-phenyl-4-propionoxypiperidine (betanrodine), alpba-3-etbyl-l-methyl-4-phenyl-4-propioD.oxypiperidine (alphameorodine), beta-3-ethyl-l-methyl-4—phenyl-4-propionoxypiperidine (betameprodine), 1t2,5-trimetbyl-4-phenyl-4-propionoxypiperidine (trimeperidine), N-(2-(N-metbylphenetbylamino)propyl)-propionanilide (diampromide), H-(l-methyl-2-piperidinoethyl)-propionanilide (phenampromide), 6—dimethylamino—4,4-diphenyl-3-heptanone (methadone), 6-rmorpholino—4,4-diphenyl-3-heptanone (phenadoxone), 4,4-diphenyl-6—piperidino-3-heptanone (jUjMjjanone,), 6-dimethylamino-4,4—diphenyl-3-hexanone (normethadone), '6-dimethylamino-5-methyl-4,4-diphenyl-3-hexanone (isomethadone), 6-dimethylamino-4,4-diphenyl-3-heptanol (dimenheptanol), alpha-6-dimethylamino-4,4-diphenyl-3-heptanol (alphamethadol), beta—6—dimethylamino-4,4-diphenyl-3-heptanol (betamethadol), 3- ^etoxy-6-dimethylamino-4t4-diphenylheptane (acetvlmethadol). ,alpha-3-acetoxy-6-dimethylamino-4,4-diphenylheptane (alphacetvlmethadol). beta-3-acetoxy-6-dimethylamino—4,4-diphenylheptane (betacetvlmethadol), (±)-alpha-3-acetoxy-6-methylamino-4,4-diphenylheptane (noracvmethadol), 4—cyano-2-dimethylamino—4,4-diphenylbutane (methadone-intermediate), 4-dimethylamino-3-methyl-l,2-diphenyl-2-propionoxybutane (propoxyphene), (ethyl—4-morpholino-2,2-diphenylbutyrate (dioxaphetvl butvrate)• 3—dimethylamino-1,l-di-(2'-thienyl)-l-butene (dimethylthiambutene), 3—etbylmetbylamino-l,l-di-(2•-thienyl)-l-butene (ethvlmethylthiambutene), 3-diethylamino-l,l-di-(2,-thienyl)-l-butene (diethylthiambutene). (-)—3—hydroxymorphinan (norlevqr-phftnnl), 3—hydroxy-N-methylmorphinan (levorphanol. racemornhan). except the dextrorotatory compound /dextrorphan/r 3-methoxy-N-methylmorphinan (leyomethorphan. racemet^orpb^)- except the dextrorotatory compound /dextrpme^orphan/. (—)—3—hydroxy-N-phenacylmorphinan (lfcvophenacvlmorphan), 3-hydroxy-N-phenethylmorphinan (phenomorph.aT'), 4- (2-metbyl-4-oxo-3,3-diphenyl-4-(1-pyrrolidinyl) butyl) morpholine (levomoramide, dextromoramide. racemoramide). 1,3-dimetbyl-4-phenyl—4-propionoxyazacycloheptane (prohentazine), - 4 - 2-methyl-3-morpb.olino-l,l-diphenylpropanecarboxylic acid (moramide- Y intermediate), l-diethvlaminoethvl-2-para-ethoxvbenzyl-5-nitrobenz imidazole ^Vl (etonitazene ), >' (2-para-chlorbenzvl)-l-diethylaminoethyl-5-nitrobenzimidazole (clonitazene). \^ 2-dimethylaminoethyl-l-ethoxy-l,l-diphenylacetate (diagnojcfidoi.), , yef 2 -hydroxy-5,9-dimethyl-2-phenethyl-6,7-benzomorphan (nhenazocine). 2 *-hydroxy-2,5,9-trime thyl-6,7-benzomorphan (metazocine). 1-phenyl-2-aminopropane (amphetamine), l-phenyl-2-methylaminopropane (methamphetamine)." 2. Section 9, subsection 2, shall read: "(2) Narcotic drugs for the dispensaries of physicians and veterinary surgeons (sections 28 to 34 of the Act of 18 December 1906, Reichsgesetzblatt No. 5 of 1907) may be obtained only from one of the ten public pharmacies nearest to their place of residence. Codeine, ethylmorphine, dihydrocodeine (paracodine), codeine nicotinic acid ester (nicocodine). acetyldihydrocodeine, morpholinylethylmorphine (t>hoICQ dine) and their salts, and pharma• ceutical preparations containing these drugs, may also be obtained from other public pharmacies." 3. Section 15, subsection 4 shall read: "(4) The provisions of subsections 2 and 3 shall not apply to prescriptions of ethyl• morphine, codeine, dihydrocodeine (paracodine), codeine nicotinic acid ester f ifir*n»od-i»^l( acetyldihydrocodeine, morpholinylethylmorphine (phoICQdine) or their salts." 4. The following shall be added to section 20, subsection 2: "When preparations of pharmaceuticals which, of the narcotic drugs referred to in Section 1 hereof, contain only codeine, ethylmorphine, dihydrocodeine (paracodine), codeine nicotinic acid ester (nicocodine). acetyldihydrocodeine or morpholinylethylmorphine (pholcodine) or their salts, are exported, only two forms of application for an export authorization (forms 1 and 2) heed be submitted. When these preparations are exported, a duplicate of the export authorization need not be attached to the shipment; nor shall the Federal Ministry of Social Administration transmit a duplicate of the export authorization to the authorities of the country of destination." 5. In Section 21 subsection 1 the words "despatching post office" (Aufgabepostamt) shall be replaced by "post office of customs clearance" (Verzollungspostamt). 6. Form 8, sheet 2, reverse side (application for export authorization) shall be amended as follows: The words "despatching post office" shall be replaced in each case by "post office of customs clearance", The term "Department 18" shall be replaced in each case by "Department 25" , and The address "Federal Ministry of Social Administration, Vienna I, Hanuschgasse 3" shall be replaced by the address "Federal Ministry of Social Administration, Vienna I, Stnbenring 1". FSOKSCH .
Recommended publications
  • Minnesota Statutes 1979 Supplement

    Minnesota Statutes 1979 Supplement

    MINNESOTA STATUTES 1979 SUPPLEMENT 152.01 PROHIBITED DRUGS CHAPTER 152. PROHIBITED DRUGS Sec. 152.01 Definitions. 152.02 Schedules of controlled substances; admin­ istration of chapter. 152.01 Definitions. [For text of subds 1 to 8, see M.S.1978] Subd. 9. Marijuana. "Marijuana" means all parts of the plant of any species of the genus Cannabis, including all agronomical varieties, whether growing or not; the seeds thereof; the resin extracted from any part of such plant; and every compound, manufacture, salt, derivative, mixture, or preparation of such plant, its seeds or resin, but shall not include the mature stalks of such plant, fiber from such stalks, oil or cake made from the seeds of such plant, any other compound, manufacture, salt, derivative, mix­ ture, or preparation of such mature stalks, except the resin extracted therefrom, fiber, oil, or cake, or the sterilized seed of such plant which is incapable of germination. [For text of subds 10 to 17, see M.S.1978] [ 1979 c 157 s 1 ] 152.02 Schedules of controlled substances; administration of chapter. [For text of subd 1, see M.S.1978) Subd. 2. The following items are listed in Schedule I: (1) Any of the following substances, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, unless specifically excepted, whenever the exis­ tence of such isomers, esters, ethers and salts is possible within the specific chemical des­ ignation: Acetylmethadol; Allylprodine; Alphacetylmethadol; Alphameprodine; Alpham- ethadol; Benzethidine; Betacetylmethadol; Betameprodine; Betamethadol; Betaprodine; Clonitazene; Dextromoramide; Dextrorphan; Diampromide; Diethyliambutene; Dime- noxadol; Dimepheptanol; Dimethyliambutene; Dioxaphetyl butyrate; Dipipanone; Ethylmethylthiambutene; Etonitazene; Etoxeridine; Furethidine; Hydroxypethidine; Ke- tobemidone; Levomoramide; Levophenacylmorphan; Morpheridine; Noracymethadol; Norlevorphanol; Normethadone; Norpipanone; Phenadoxone; Phenampromide; Pheno- morphan; Phenoperidine; Piritramide; Proheptazine; Properidine; Racemoramide; Tri­ meperidine.
  • Pharmacy and Poisons (Third and Fourth Schedule Amendment) Order 2017

    Pharmacy and Poisons (Third and Fourth Schedule Amendment) Order 2017

    Q UO N T FA R U T A F E BERMUDA PHARMACY AND POISONS (THIRD AND FOURTH SCHEDULE AMENDMENT) ORDER 2017 BR 111 / 2017 The Minister responsible for health, in exercise of the power conferred by section 48A(1) of the Pharmacy and Poisons Act 1979, makes the following Order: Citation 1 This Order may be cited as the Pharmacy and Poisons (Third and Fourth Schedule Amendment) Order 2017. Repeals and replaces the Third and Fourth Schedule of the Pharmacy and Poisons Act 1979 2 The Third and Fourth Schedules to the Pharmacy and Poisons Act 1979 are repealed and replaced with— “THIRD SCHEDULE (Sections 25(6); 27(1))) DRUGS OBTAINABLE ONLY ON PRESCRIPTION EXCEPT WHERE SPECIFIED IN THE FOURTH SCHEDULE (PART I AND PART II) Note: The following annotations used in this Schedule have the following meanings: md (maximum dose) i.e. the maximum quantity of the substance contained in the amount of a medicinal product which is recommended to be taken or administered at any one time. 1 PHARMACY AND POISONS (THIRD AND FOURTH SCHEDULE AMENDMENT) ORDER 2017 mdd (maximum daily dose) i.e. the maximum quantity of the substance that is contained in the amount of a medicinal product which is recommended to be taken or administered in any period of 24 hours. mg milligram ms (maximum strength) i.e. either or, if so specified, both of the following: (a) the maximum quantity of the substance by weight or volume that is contained in the dosage unit of a medicinal product; or (b) the maximum percentage of the substance contained in a medicinal product calculated in terms of w/w, w/v, v/w, or v/v, as appropriate.
  • Thieme: Pharmakologie Und Toxikologie

    Thieme: Pharmakologie Und Toxikologie

    627 Sachverzeichnis Vorbemerkung: Im Text des Buches sind für Wirkstoffe immer die internationalen Freinamen benutzt. Im Register sind die Handels- namen mit ௡ gekennzeichnet. Die Handelsnamen sind in den Tabellen „Notwendige Wirkstoffe“ aufgelistet. A Acetyldigoxin 149 Adenosin 139, 163 – Struktur 145 – als Antiarrhythmikum 162 Abacavir 532, 534 Acetylierer, langsamer 59 – Schmerzempfindung 289 Abarelix 399f Acetylsalicylsäure 310, 314ff – Struktur 139 Abatacept 331 – bei akutem rheumatischen Fieber 324 Adenosindesaminase 462 – bei rheumatoider Arthritis 322 – bei Angina pectoris 182 Adenosindiphosphat 139 ABC-Transporter 30 – Anwendung 314 Adenosinmonophosphat, zyklisches 99f Abciximab 183, 209 – bei Herzinfarkt 184 Adenosin-Nukleotid 139 – Thrombozytenaggregationshemmung – Kontraindikation 316 Adenosin-Rezeptor 139 207 – Metabolismus 315 Adenosintriphosphat 139 Abführmittel-Colon 246 – bei Migräne 307 – Schmerzempfindung 289 Abhängigkeit 49 – Nebenwirkung 315 – als Überträgersubstanz 139 – Hypnotika 363 – Pharmakokinetik 314f Adenylatcyclase 8, 100 Abilify௡ 346 – Re-Infarkt-Prophylaxe 184 Adermin 271 Absence – bei Schlaganfall 186 Adevofir-dipivoxil bei Hepatitis B 253 – Antiepileptikawahl 375 – Schmerztherapie, Stufenschema 305 ADH (antidiuretisches Hormon) s. Adiu- – pyknoleptische, Antiepileptikawahl – Schwangerschaft 316 retin 375 – Struktur 315 Adhäsionsprotein 333 Absorption s. Resorption – Thromboseprophylaxe 209 ADHS (Aufmerksamkeits-Defizit/Hyper- Abstillen 404 – Thrombosetherapie 209 aktivitäts-Syndrom) 362 Acamprosat bei
  • Federal Register/Vol. 84, No. 26/Thursday, February 7, 2019/Notices

    Federal Register/Vol. 84, No. 26/Thursday, February 7, 2019/Notices

    2570 Federal Register / Vol. 84, No. 26 / Thursday, February 7, 2019 / Notices National Fire Protection Association Register pursuant to Section 6(b) of the Morrissette Drive, Springfield, Virginia (‘‘NFPA’’) has filed written notifications Act on October 22, 2018 (83 FR 53297). 22152. simultaneously with the Attorney Suzanne Morris, SUPPLEMENTARY INFORMATION: General and the Federal Trade The Commission disclosing additions or Chief, Premerger and Division Statistics Unit, Attorney General has delegated his changes to its standards development Antitrust Division. authority under the Controlled activities. The notifications were filed [FR Doc. 2019–01489 Filed 2–6–19; 8:45 am] Substances Act to the Administrator of for the purpose of extending the Act’s BILLING CODE 4410–11–P the Drug Enforcement Administration provisions limiting the recovery of (DEA), 28 CFR 0.100(b). Authority to antitrust plaintiffs to actual damages exercise all necessary functions with under specified circumstances. DEPARTMENT OF JUSTICE respect to the promulgation and implementation of 21 CFR part 1301, Specifically, NFPA has provided an Drug Enforcement Administration updated and current list of its standards incident to the registration of development activities, related technical [Docket No. DEA–392] manufacturers, distributors, dispensers, committee and conformity assessment importers, and exporters of controlled activities. Information concerning NFPA Bulk Manufacturer of Controlled substances (other than final orders in regulations, technical committees,

  • Controlled Drug Schedules, Violations & Penalties

    CONTROLLED DRUG SCHEDULES, VIOLATIONS & PENALTIES A REFERENCE FOR THE LAW ENFORCEMENT COMMUNITY April 2015 Prepared by the DEPARTMENT OF CONSUMER PROTECTION Drug Control Division TABLE OF CONTENTS SECTION I CONTROLLED DRUG SCHEDULES & VIOLATIONS An alphabetical listing of controlled drugs by their brand, generic and/or street name that includes each drug’s schedule and the violation(s) from the Connecticut General Statutes (CGS) that are associated with each drug’s sale and/or possession. SECTION II CONTROLLED DRUG VIOLATIONS & PENALTIES A numerical listing of controlled drug violations by their section number in the Connecticut General Statutes (CGS) and the penalty(ies) associated with each violation. SECTION III SUMMARY OF FEDERAL METHAMPHETAMINE STATUTES 2 S E C T I O N I CONTROLLED DRUG SCHEDULES & VIOLATIONS The ‘Schedules of Controlled Substances’ may be found in Sections 21a-243-7 through 21a-243-11, inclusive, of the Regulations of Connecticut State Agencies. www.ct.gov/dcp/lib/dcp/dcp_regulations/21a-243_designation_of_controlled_drugs.pdf 3 Drug State CS Drug Type AKA Sale or Quantity Person Drug- CGS Schedule Possession? Dependent or Not Violation APAP = Acetaminophen APAP = Acetaminophen Drug-Dependent ? ASA = Aspirin ASA = Aspirin “2C-C” Designer Drug - Stimulant “Bath Salts” Federal CS Schedule 1 “2C-D” Designer Drug - Stimulant “Bath Salts” Federal CS Schedule 1 “2C-E” Designer Drug - Stimulant “Bath Salts” Federal CS Schedule 1 “2C-H” Designer Drug - Stimulant “Bath Salts” Federal CS Schedule 1 “2C-I” Designer Drug - Stimulant
  • Ehealth DSI [Ehdsi V2.2.2-OR] Ehealth DSI – Master Value Set

    Ehealth DSI [Ehdsi V2.2.2-OR] Ehealth DSI – Master Value Set

    MTC eHealth DSI [eHDSI v2.2.2-OR] eHealth DSI – Master Value Set Catalogue Responsible : eHDSI Solution Provider PublishDate : Wed Nov 08 16:16:10 CET 2017 © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 1 of 490 MTC Table of Contents epSOSActiveIngredient 4 epSOSAdministrativeGender 148 epSOSAdverseEventType 149 epSOSAllergenNoDrugs 150 epSOSBloodGroup 155 epSOSBloodPressure 156 epSOSCodeNoMedication 157 epSOSCodeProb 158 epSOSConfidentiality 159 epSOSCountry 160 epSOSDisplayLabel 167 epSOSDocumentCode 170 epSOSDoseForm 171 epSOSHealthcareProfessionalRoles 184 epSOSIllnessesandDisorders 186 epSOSLanguage 448 epSOSMedicalDevices 458 epSOSNullFavor 461 epSOSPackage 462 © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 2 of 490 MTC epSOSPersonalRelationship 464 epSOSPregnancyInformation 466 epSOSProcedures 467 epSOSReactionAllergy 470 epSOSResolutionOutcome 472 epSOSRoleClass 473 epSOSRouteofAdministration 474 epSOSSections 477 epSOSSeverity 478 epSOSSocialHistory 479 epSOSStatusCode 480 epSOSSubstitutionCode 481 epSOSTelecomAddress 482 epSOSTimingEvent 483 epSOSUnits 484 epSOSUnknownInformation 487 epSOSVaccine 488 © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 3 of 490 MTC epSOSActiveIngredient epSOSActiveIngredient Value Set ID 1.3.6.1.4.1.12559.11.10.1.3.1.42.24 TRANSLATIONS Code System ID Code System Version Concept Code Description (FSN) 2.16.840.1.113883.6.73 2017-01 A ALIMENTARY TRACT AND METABOLISM 2.16.840.1.113883.6.73 2017-01
  • Chapter 329 [New] Uniform Controlled Substances Act

    Chapter 329 [New] Uniform Controlled Substances Act

    CHAPTER 329 [NEW] UNIFORM CONTROLLED SUBSTANCES ACT Part I. General Provisions Section 329-1 Definitions 329-2 Hawaii advisory commission on drug abuse and controlled substances; number; appointment 329-3 Annual report 329-4 Duties of the commission Part II. Standards and Schedules 329-11 Authority to schedule controlled substances 329-12 Nomenclature 329-13 Schedule I tests 329-14 Schedule I 329-15 Schedule II tests 329-16 Schedule II 329-17 Schedule III Tests 329-18 Schedule III 329-19 Schedule IV tests 329-20 Schedule IV 329-21 Schedule V tests 329-22 Schedule V 329-23 Republishing and distribution of schedules Part III. Regulation of Manufacture, Distribution, Prescription, and Dispensing of Controlled Substances 329-31 Rules 329-31.5 Clinics 329-32 Registration requirements 329-33 Registration 329-34 Revocation and suspension of registration 329-35 Order to show cause 329-36 Records of registrants 329-37 Filing requirements 329-38 Prescriptions 329-39 Labels 329-40 Methadone treatment programs Part IV. Offenses and Penalties 329-41 Prohibited acts B-penalties 329-42 Prohibited acts C-penalties 329-43 Penalties under other laws 329-43.5 Prohibited acts related to drug paraphernalia Amended 0612 1 329-44 Notice of conviction to be sent to licensing board, department of commerce and consumer affairs 329-45 Repealed 329-46 Prohibited acts related to visits to more than one practitioner to obtain controlled substance prescriptions 329-49 Administrative penalties 329-50 Injunctive relief Part V. Enforcement and Administrative Provisions 329-51 Powers of enforcement personnel 329-52 Administrative inspections 329-53 Injunctions 329-54 Cooperative arrangements and confidentiality 329-55 Forfeitures 329-56 Burden of proof; liabilities 329-57 Judicial review 329-58 Education and research 329-59 Controlled substance registration revolving fund; established Part VI.
  • Supplement 1: Additional Tables and Figures

    Supplement 1: Additional Tables and Figures

    BMJ Publishing Group Limited (BMJ) disclaims all liability and responsibility arising from any reliance Supplemental material placed on this supplemental material which has been supplied by the author(s) BMJ Global Health Supplement 1: Additional tables and figures Box S1: Substances included and excluded from the International Narcotic Control Board (INCB) data on narcotic consumption, in alphabetical order. Opioids included in the opioid consumption calculation: 1. (+)-cis-3-methylfental 35. Bezitramide 2. 3-Acetylmorphine 36. Butyrfentanyl 3. 3-Methylfentanyl 37. Carfentanil 4. 3-Methylthiofentanyl 38. Carfentanyl 5. 3-Monoacetylmorphine 39. Clonitazene 6. 4-Fluoroisobutyrfentanyl 40. Codeine 7. 6-Acetylmorphine 41. Codeine-6GLUC 8. 6-Monoacetylmorphine 42. Codeine-6-glucuronide 9. Acetorphine 43. Codeine-Methyl 10. Acetyl-alpha-methylfentanyl 44. Codeine-N-oxide 11. Acetyldihydrocodeine 45. Codoxime 12. Acetylfentanyl 46. Conc. of poppy straw (C) ACA 13. Acetylmethadol 47. Conc. of poppy straw (C) AMA 14. Acetylmorphine 48. Conc. of poppy straw (C) AOA 15. Acrylfentanyl 49. Conc. of poppy straw (C) ATA 16. AH-7921 50. Conc. of poppy straw (C) GW 17. Alfentanil 51. Conc. of poppy straw (M) ACA 18. Allylprodine 52. Conc. of poppy straw (M) AMA 19. Alphacetylmethadol 53. Conc. of poppy straw (M) AOA 20. Alphameprodine 54. Conc. of poppy straw (M) ATA 21. Alphamethadol 55. Conc. of poppy straw (M) GW 22. alpha-Methylfentanyl 56. Conc. of poppy straw (N) GW 23. alpha-Methylthiofentanyl 57. Conc. of poppy straw (O) 24. Alphaprodine 58. Conc. of poppy straw (O) ACA 25. Anileridine 59. Conc. of poppy straw (O) AMA 26. Benzethidine 60. Conc. of poppy straw (O) AOA 27.
  • List of Narcotic Substances Circulation of Which Is Restricted in Uzbekistan

    List of Narcotic Substances Circulation of Which Is Restricted in Uzbekistan

    List of narcotic substances circulation of which is restricted in Uzbekistan 1. 2C-B(4-bromo-2,5-dimethoxyphenethylamine) 2. 3-methylfentanyl 3. 3-methylthiofentanyl 4. 3-Monoacetylmorphine 5. 4-methylaminorex 6. 6- Monoacetylmorphine 7. Acetorphine 8. Acetyl Dihydrocodeine 9. Acetyl-alfametilfentanil 10. Acetylated opium 11. Acetylcodeine 12. Acetylmethadol 13. Alfametadol 14. Alfatsetilmetadol 15. all fungi that contain Psilocine and Psilocybine 16. Allylprodine 17. Alpha Methylfentanyl 18. Alpha Metiltiofentanil 19. Alphaprodine 20. Anileridin 21. Benzethidine 22. Benzylmorphine 23. Betacetylmethadol 24. Betahydroxyfentanyl 25. Betameprodine 26. Betamethadol 27. Betaprodine 28. Bezitramide 29. Cannabis oil (hashish oil) 30. Cannabis, marihuana 31. Cathine ((+)-norpseudoephedrine) 32. Cathinone (l-alpha-aminopropiofenon) 33. Clonitazene 34. Cocaine 35. Codoxime 36. d- Methadone 37. DB [L-(3,4 - methylenedioxyphenyl) -2 butanamine] 38. Desmethylprodine; MPPP (1-methyl-4-phenyl-4-propionoxypiperidine) 39. Desomorphine 40. DET (N,N-diethyltryptamine) 41. Dexamphetamine 42. Diampromide 43. Diethyl phosphate 44. Diethylthiambutene 45. Dihydromorphine 46. Dimenoxadol 47. Dimepheptanol 48. Dimethylthiambutene 49. Dioxaphetyl butyrate 50. Diphenoxine 51. Dipipanone 52. DMA (2,5-dimethoxyamphetamine) 53. DMGP (dimetilgeptilpiran) 54. DMT (dimethyltryptamine) 55. DOB (d, L-2,5-dimethoxy-4-bromo-amphetamine) 56. DOC (d, L-2,5-dimethoxy-4-chloro-amphetamine) 57. DOET (2,5-dimethoxy-4-ethylamphetamine) 58. Drotebanol 59. Ecgonine 60. Ephedrone 61. Ethylmethylthiambutene 62. Eticyclidine 63. Etonitazene 64. Etorphine 65. Etoxeridine 66. Etryptamine 67. Furethidine 68. Hashish (Anasha, cannabis resin) 69. Heroin (Diacetylmorphine) 70. Hydrocodone 71. Hydrocodone phosphate 72. Hydromorphinol 73. Hydromorphone 74. Isomethadone 75. Ketobemidone 76. Khat 77. L- Methadone 78. Levomethorphan 79. Levomoramide 80. Levophenacylmorphan 81. Levorphanol 82. Lysergic acid and its preparations, that include d-Lysergide (LSD, LSD-25) 83.
  • List of Narcotic Drugs Under International Control

    List of Narcotic Drugs Under International Control

    International Narcotics Control Board Yellow List Annex to Forms A, B and C 59th edition, July 2020 LIST OF NARCOTIC DRUGS UNDER INTERNATIONAL CONTROL Prepared by the INTERNATIONAL NARCOTICS CONTROL BOARD* Vienna International Centre P.O. Box 500 A-1400 Vienna, Austria Internet address: http://www.incb.org/ in accordance with the Single Convention on Narcotic Drugs, 1961** Protocol of 25 March 1972 amending the Single Convention on Narcotic Drugs, 1961 * On 2 March 1968, this organ took over the functions of the Permanent Central Narcotics Board and the Drug Supervisory Body, r etaining the same secretariat and offices. ** Subsequently referred to as “1961 Convention”. V.20-03697 (E) *2003697* Purpose The Yellow List contains the current list of narcotic drugs under international control and additional relevant information. It has been prepared by the International Narcotics Control Board to assist Governments in completing the annual statistical reports on narcotic drugs (Form C), the quarterly statistics of imports and exports of narcotic drugs (Form A) and the estimates of annual requirements for narcotic drugs (Form B) as well as related questionnaires. The Yellow List is divided into four parts: Part 1 provides a list of narcotic drugs under international control in the form of tables and is subdivided into three sections: (1) the first section includes the narcotic drugs listed in Schedule I of the 1961 Convention as well as intermediate opiate raw materials; (2) the second section includes the narcotic drugs listed in Schedule II of the 1961 Convention; and (3) the third section includes the narcotic drugs listed in Schedule IV of the 1961 Convention.
  • (12) Patent Application Publication (10) Pub. No.: US 2014/0144429 A1 Wensley Et Al

    (12) Patent Application Publication (10) Pub. No.: US 2014/0144429 A1 Wensley Et Al

    US 2014O144429A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2014/0144429 A1 Wensley et al. (43) Pub. Date: May 29, 2014 (54) METHODS AND DEVICES FOR COMPOUND (60) Provisional application No. 61/887,045, filed on Oct. DELIVERY 4, 2013, provisional application No. 61/831,992, filed on Jun. 6, 2013, provisional application No. 61/794, (71) Applicant: E-NICOTINE TECHNOLOGY, INC., 601, filed on Mar. 15, 2013, provisional application Draper, UT (US) No. 61/730,738, filed on Nov. 28, 2012. (72) Inventors: Martin Wensley, Los Gatos, CA (US); Publication Classification Michael Hufford, Chapel Hill, NC (US); Jeffrey Williams, Draper, UT (51) Int. Cl. (US); Peter Lloyd, Walnut Creek, CA A6M II/04 (2006.01) (US) (52) U.S. Cl. CPC ................................... A6M II/04 (2013.O1 (73) Assignee: E-NICOTINE TECHNOLOGY, INC., ( ) Draper, UT (US) USPC ..................................................... 128/200.14 (21) Appl. No.: 14/168,338 (57) ABSTRACT 1-1. Provided herein are methods, devices, systems, and computer (22) Filed: Jan. 30, 2014 readable medium for delivering one or more compounds to a O O Subject. Also described herein are methods, devices, systems, Related U.S. Application Data and computer readable medium for transitioning a Smoker to (63) Continuation of application No. PCT/US 13/72426, an electronic nicotine delivery device and for Smoking or filed on Nov. 27, 2013. nicotine cessation. Patent Application Publication May 29, 2014 Sheet 1 of 26 US 2014/O144429 A1 FIG. 2A 204 -1 2O6 Patent Application Publication May 29, 2014 Sheet 2 of 26 US 2014/O144429 A1 Area liquid is vaporized Electrical Connection Agent O s 2.
  • Tennessee Drug Statutes (Listed in Numerical Order)

    Tennessee Drug Statutes (Listed in Numerical Order)

    Tennessee Drug Statutes (listed in numerical order) 39-17-405. Criteria for Schedule I. • The commissioner of mental health and substance abuse services, upon the agreement of the commissioner of health, shall place a substance in Schedule I upon finding that the substance has: o (1) High potential for abuse; and o (2) No accepted medical use in treatment in the United States or lacks accepted safety for use in treatment under medical supervision. 39-17-406. Controlled substances in Schedule I. • (a) Schedule I consists of the drugs and other substances, by whatever official name, common or usual name, chemical name, or brand name designated, listed in this section. • (b) Opiates, unless specifically excepted or unless listed in another schedule, means any of the following opiates, including their isomers, esters, ethers, salts and salts of isomers, esters, and ethers, whenever the existence of such isomers, esters, ethers, and salts is possible within the specific chemical designation. For the purposes of subdivision (b)(34) only, the term isomer includes the optical and geometric isomers. o (1) Acetyl-alpha-methylfentanyl (N-[1-(1-methyl-2-phenethyl)-4- piperidinyl]-N-phenylacetamide); o (2) Acetylmethadol; o (3) Allylprodine; o (4) Alphacetylmethadol (except levo-alphacetylmethadol also known as levo-alpha-acetylmethadol; levomethadyl acetate; or LAAM); o (5) Alphameprodine; o (6) Alphamethadol; o (7) Alpha-methylfentanyl (N-[1-(alpha-methyl-beta-phenyl)ethyl-4- piperidyl]propionanilide; 1-(1-methyl-2-phenylethyl)-4-(N- propanilido)piperidine;